Episode Details
Back to Episodes
Takeda and Insilico Team Up on AI Drugs | Tech News
Description
Takeda teams up with Insilico Medicine to supercharge drug discovery using AI, granting exclusive rights to new medicines while Insilico handles AI-driven target identification and molecule design. This marks Takeda’s latest leap into AI-powered research, following a similar cancer-focused deal with Iambic. Insilico, already in clinical trials with an AI-generated lung drug and backed by major partners like Eli Lilly and SK Biopharmaceuticals, sees its stock soar after the announcement — signaling a bold industry shift toward AI to accelerate next-gen treatments.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/86f928b8f3617612